Stockscreener 앱 받기
14.98
1.83%
-0.28
BlossomHill Therapeutics, Inc. Common Stock 주식(BLSM)의 최신 뉴스
Latigo Biotherapeutics, Inc. Common Stock (LTGO) Earnings Reports & Dates - FXEmpire
Leerink Partners Boosts BlossomHill Therapeutics (NASDAQ:BLSM) Price Target to $40.00 - marketbeat.com
BlossomHill Therapeutics (NASDAQ:BLSM) Hits New 12-Month HighShould You Buy? - marketbeat.com
BlossomHill Therapeutics (NASDAQ:BLSM) Announces Earnings Results, Misses Estimates By $7.91 EPS - MarketBeat
BlossomHill Therapeutics Reports Second Quarter 2026 Financial Results - Stock Titan
BlossomHill Therapeutics Reports Second Quarter 2026 Financial Results - GlobeNewswire
BlossomHill Therapeutics (NASDAQ:BLSM) Stock Price Up 5.8%What's Next? - marketbeat.com
BlossomHill Therapeutics (NASDAQ:BLSM) Reaches New 12-Month HighWhat's Next? - marketbeat.com
BlossomHill stock surges on positive lung cancer trial data By Investing.com - Investing.com South Africa
An experimental lung cancer drug kept disease under control in 88% of 40 patients - Stock Titan
BlossomHill Therapeutics, Inc.'s Quiet Period Set To Expire on September 16th (NASDAQ:BLSM) - marketbeat.com
BlossomHill Therapeutics (NASDAQ:BLSM) Shares Gap UpHere's Why - marketbeat.com
BlossomHill Therapeutics (NASDAQ:BLSM) Stock Rating Upgraded by Guggenheim - marketbeat.com
BlossomHill Therapeutics, Inc. (NASDAQ:BLSM) Given Average Rating of "Buy" by Brokerages - marketbeat.com
Patients whose lung cancer develops a specific resistance mutation after a targeted drug stops working have no approved pills aimed at it. BlossomHill Therapeutics plans to present updated trial data on Sept. 15. - Stock Titan
BlossomHill (NASDAQ: BLSM) insider buys at $16 and gets options - Stock Titan
OrbiMed adds BlossomHill Therapeutics (BLSM) IPO stake with insider buy - Stock Titan
BlossomHill Therapeutics Insider Bought Shares Worth $5,000,000, According to a Recent SEC Filing - Yahoo Finance
BlossomHill, Latigo bloom on Nasdaq with oversubscribed IPOs - BioSpace
BlossomHill Therapeutics completes IPO and updates governance - TipRanks
BlossomHill Therapeutics shares fall in debut after IPO - Investing.com
BlossomHill Therapeutics Prices Upsized Nasdaq IPO - Yahoo Finance
Latham & Watkins Advises on BlossomHill Therapeutics’ Upsized US$150 Million IPO - Latham & Watkins LLP
BlossomHill Therapeutics Prices Upsized $150 Million Initial Public Offering | BLSM Stock News - Quiver Quantitative
BlossomHill Therapeutics, Inc.BLSMStock Price Today - Zacks Investment Research
BlossomHill Therapeutics Announces Pricing of Upsized $150 Million Initial Public Offering - GlobeNewswire
BlossomHill Therapeutics (BLSM) director holds $13.59 option to 2036 - Stock Titan
BlossomHill Therapeutics prices $150M IPO at $16 per share - Investing.com
BlossomHill Therapeutics Aims For $125 Million IPO On Cancer Treatment Pipeline Promise - Seeking Alpha
BlossomHill Therapeutics files for Nasdaq IPO at up to $17 per share - Investing.com
BlossomHill Therapeutics files for Nasdaq IPO at up to $17 per share - Investing.com Nigeria
BlossomHill Therapeutics files for Nasdaq IPO under ticker BLSM - Investing.com
BlossomHill Therapeutics, Clinical-Stage Oncology Biotech, Files for Nasdaq Global Select Market IPO - TradingView
BlossomHill Therapeutics prices $150M IPO at $16 per share By Investing.com - Investing.com Nigeria
SGMT Stock Price and Chart — NASDAQ:SGMT - TradingView
ZVRA Stock Price and Chart — NASDAQ:ZVRA - TradingView
Greenwave Technology Solutions, Inc. Common Stock (GWAV) Historical Quotes - nasdaq.com
PHAT Stock Price and Chart — NASDAQ:PHAT - TradingView
AQST Stock Price and Chart — NASDAQ:AQST - TradingView
ACRS Stock Price and Chart — NASDAQ:ACRS - TradingView
IRWD Stock Price and Chart — NASDAQ:IRWD - tradingview.com
1.35%
자본화:
|
볼륨(24시간):